Name
PANEL: Pharma Insights: Designing phage-based clinical trials to prove efficacy.
Date & Time
Wednesday, February 24, 2021, 9:20 AM - 10:00 AM
Speakers
Henry ‘Chip’ Chambers - UC San Francisco
Todd Black - Merck & Co.
Bob Blasdel - Vésale Pharmaceutica
Kristin Wannerberger - Ferring Pharmaceuticals
Henry ‘Chip’ Chambers Todd Black Bob Blasdel Kristin Wannerberger
Description

· How do pharmaceutical companies set up their clinical trials to ensure success? · What lessons can be learnt from past phage-based clinical trials & how would pharma have designed them differently? · How should phage therapy researchers design clinical trials going forward to improve confidence in phagebased drug efficacy?

Virtual Session Link
View Session